IBDEI1VH ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32947,2)
 ;;=^5000062
 ;;^UTILITY(U,$J,358.3,32948,0)
 ;;=B20.^^182^1994^26
 ;;^UTILITY(U,$J,358.3,32948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32948,1,3,0)
 ;;=3^HIV Disease
 ;;^UTILITY(U,$J,358.3,32948,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,32948,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,32949,0)
 ;;=B02.9^^182^1994^85
 ;;^UTILITY(U,$J,358.3,32949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32949,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,32949,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,32949,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,32950,0)
 ;;=A60.9^^182^1994^2
 ;;^UTILITY(U,$J,358.3,32950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32950,1,3,0)
 ;;=3^Anogenital Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,32950,1,4,0)
 ;;=4^A60.9
 ;;^UTILITY(U,$J,358.3,32950,2)
 ;;=^5000359
 ;;^UTILITY(U,$J,358.3,32951,0)
 ;;=A60.04^^182^1994^29
 ;;^UTILITY(U,$J,358.3,32951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32951,1,3,0)
 ;;=3^Herpesviral Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,32951,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,32951,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,32952,0)
 ;;=A60.01^^182^1994^27
 ;;^UTILITY(U,$J,358.3,32952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32952,1,3,0)
 ;;=3^Herpesviral Infection of Penis
 ;;^UTILITY(U,$J,358.3,32952,1,4,0)
 ;;=4^A60.01
 ;;^UTILITY(U,$J,358.3,32952,2)
 ;;=^5000353
 ;;^UTILITY(U,$J,358.3,32953,0)
 ;;=B00.1^^182^1994^28
 ;;^UTILITY(U,$J,358.3,32953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32953,1,3,0)
 ;;=3^Herpesviral Vesicular Dermatitis
 ;;^UTILITY(U,$J,358.3,32953,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,32953,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,32954,0)
 ;;=B97.89^^182^1994^81
 ;;^UTILITY(U,$J,358.3,32954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32954,1,3,0)
 ;;=3^Viral Agent Cause of Disease
 ;;^UTILITY(U,$J,358.3,32954,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,32954,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,32955,0)
 ;;=B97.10^^182^1994^20
 ;;^UTILITY(U,$J,358.3,32955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32955,1,3,0)
 ;;=3^Enterovirus Cause of Disease
 ;;^UTILITY(U,$J,358.3,32955,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,32955,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,32956,0)
 ;;=B34.9^^182^1994^82
 ;;^UTILITY(U,$J,358.3,32956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32956,1,3,0)
 ;;=3^Viral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,32956,1,4,0)
 ;;=4^B34.9
 ;;^UTILITY(U,$J,358.3,32956,2)
 ;;=^5000603
 ;;^UTILITY(U,$J,358.3,32957,0)
 ;;=A69.20^^182^1994^45
 ;;^UTILITY(U,$J,358.3,32957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32957,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,32957,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,32957,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,32958,0)
 ;;=A69.22^^182^1994^47
 ;;^UTILITY(U,$J,358.3,32958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32958,1,3,0)
 ;;=3^Neurologic Disorders d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,32958,1,4,0)
 ;;=4^A69.22
 ;;^UTILITY(U,$J,358.3,32958,2)
 ;;=^5000377
 ;;^UTILITY(U,$J,358.3,32959,0)
 ;;=A69.21^^182^1994^46
 ;;^UTILITY(U,$J,358.3,32959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32959,1,3,0)
 ;;=3^Meningitis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,32959,1,4,0)
 ;;=4^A69.21
 ;;^UTILITY(U,$J,358.3,32959,2)
 ;;=^5000376
 ;;^UTILITY(U,$J,358.3,32960,0)
 ;;=A69.29^^182^1994^17
 ;;^UTILITY(U,$J,358.3,32960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32960,1,3,0)
 ;;=3^Conditions d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,32960,1,4,0)
 ;;=4^A69.29
 ;;^UTILITY(U,$J,358.3,32960,2)
 ;;=^5000379
 ;;^UTILITY(U,$J,358.3,32961,0)
 ;;=A69.23^^182^1994^5
 ;;
 ;;$END ROU IBDEI1VH
